Clinical Trial Update: Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ciprofloxacin for the prevention of meningococcal meningitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis Meningococcal

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Epicentre | Conditions: Meningitis, Meningococcal | Phase 4 | Status: WITHDRAWN